Drugs / BBIBP Bivalent Oral Poliomyelitis Vaccine
last change Jun 2016 re-read 3 minutes ago

BBIBP Bivalent Oral Poliomyelitis Vaccine

Vaccine

Developed for
poliomyelitis
Investigated by
Beijing Bio-Institute Biological Products Co., Ltd., formerly Beijing TiantanBio · PATH

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02434770 Aug 2015 → Jun 2016 poliomyelitis PATH Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BBIBP Bivalent Oral Poliomyelitis Vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02434770 ↗
Modality Vaccine “liquid bivalent oral polio vaccine (bOPV)” NCT02434770 ↗
Route Oral “administered directly into the mouth” NCT02434770 ↗